These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10342086)

  • 21. Vaginal epithelial surface appearances in women using vaginal rings for contraception.
    Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Lähteenmäki P; Elomaa K; Weisberg E; Nash HA
    Contraception; 2000 Feb; 61(2):131-8. PubMed ID: 10802278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyurethane contraceptive vaginal sponge: product modifications resulting from user experience.
    Aznar R; Zamora G; Lozano M; Levi C
    Contraception; 1981 Sep; 24(3):235-44. PubMed ID: 7030612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do Women Find the Progesterone Vaginal Ring Acceptable? Findings from Kenya, Nigeria, and Senegal.
    RamaRao S; Obare F; Ishaku S; Mané B; Clark H; Liambila W; Unumeri G; Birungi H; Diop N; Rajamani D; Townsend J
    Stud Fam Plann; 2018 Mar; 49(1):71-86. PubMed ID: 29393513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High acceptability and satisfaction with NuvaRing use.
    Szarewski A
    Eur J Contracept Reprod Health Care; 2002 Dec; 7(sup2):31-36. PubMed ID: 29243955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The vaginal contraceptive pill.
    Coutinho E
    IPPF Med Bull; 1985 Feb; 19(1):2-3. PubMed ID: 12339969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study on the efficacy, acceptability, and side effects of a contraceptive pill administered by the oral and the vaginal route: an international multicenter clinical trial.
    Coutinho EM; Mascarenhas I; de Acosta OM; Flores JG; Gu ZP; Ladipo OA; Adekunle AO; Otolorin EO; Shaaban MM; Abul Oyoon M
    Clin Pharmacol Ther; 1993 Nov; 54(5):540-5. PubMed ID: 8222497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring.
    Bounds W; Szarewski A; Lowe D; Guillebaud J
    Eur J Obstet Gynecol Reprod Biol; 1993 Feb; 48(2):123-5. PubMed ID: 8491331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lea's Shield contraceptive device: pilot study of its short-term patient acceptability and aspects of use.
    Bounds W; Guillebaud J
    Br J Fam Plann; 1999 Jan; 24(4):117-20. PubMed ID: 10023094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.
    Sivin I; Díaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu SC; Du M; Alvarez F; Brache V; Basnayake S; McCarthy T; Lacarra M; Mishell DR; Koetsawang S; Stern J; Jackanicz T
    Contraception; 1997 Apr; 55(4):225-32. PubMed ID: 9179454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progesterone-releasing vaginal rings for use in postpartum contraception. II. Pharmacokinetic profiles in women.
    Landgren BM; Hall PE; Cekan SZ
    Contraception; 1992 Apr; 45(4):343-9. PubMed ID: 1516366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hormonal ring: a new contraceptive gains acceptance.
    Asian Pac Popul Programme News; 1984 Dec; 13(4):39-40. PubMed ID: 12313703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contraceptive effect of varying dosages of progestogen in silastic vaginal rings.
    Mishell DR; Lumkin ME
    Fertil Steril; 1970 Feb; 21(2):99-103. PubMed ID: 5414562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current status of contraceptive vaginal rings].
    Elstein M; Jackson R; Hickling D; Assendorp R
    Contracept Fertil Sex (Paris); 1992 Jan; 20(1):15-9. PubMed ID: 12343624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The female condom tested.
    AIDS Health Promot Exch; 1992; (4):6. PubMed ID: 12318244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adolescent and young women's experience with the vaginal ring and oral contraceptive pills.
    Stewart FH; Brown BA; Raine TR; Weitz TA; Harper CC
    J Pediatr Adolesc Gynecol; 2007 Dec; 20(6):345-51. PubMed ID: 18082856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing: results of clinical experience in Germany.
    Brucker C; Karck U; Merkle E
    Eur J Contracept Reprod Health Care; 2008 Mar; 13(1):31-8. PubMed ID: 17853162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collagen sponge as vaginal contraceptive barrier: critical summary of seven years of research.
    Chvapil M; Droegemueller W; Heine MW; MacGregor JC; Dotters D
    Am J Obstet Gynecol; 1985 Feb; 151(3):325-9. PubMed ID: 2982268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of Neo Sampoon, Ortho Vaginal Tablets and Emko Vaginal Tablets in Accra, Ghana.
    Lamptey P; Klufio C; Smith SC; Feldblum PJ
    Contraception; 1985 Nov; 32(5):445-54. PubMed ID: 3002720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in Chilean nursing women.
    Massai R; Miranda P; Valdés P; Lavín P; Zepeda A; Casado ME; Silva MA; Fetis G; Bravo C; Chandía O; Peralta O; Croxatto HB; Díaz S
    Contraception; 1999 Jul; 60(1):9-14. PubMed ID: 10549447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.